Skip to content
OpenCapital
Get started

Repligen RGEN Increase (decrease) in all other liabilities

Increase (decrease) in all other liabilities at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
——

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$7.45B-7.1%
Enterprise value$7.55B+2.1%
P/E144.9×—
P/S10.1×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
Net margin17.1%-3.7pp
FCF margin21.2%+6.1pp

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's increase (decrease) in all other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's increase (decrease) in all other liabilities?
Repligen (RGEN) reported increase (decrease) in all other liabilities of $1.27M in Q1 2026.
How has Repligen's increase (decrease) in all other liabilities changed year-over-year?
Repligen's increase (decrease) in all other liabilities increased by 167.2% year-over-year, from $475K to $1.27M.
What is the long-term trend for Repligen's increase (decrease) in all other liabilities?
Over 2 years (2022 to 2025), Repligen's increase (decrease) in all other liabilities has grown at a 27.0% compound annual growth rate (CAGR), from $966K to -$1.56M.
What does increase (decrease) in all other liabilities mean?
Represents the net change in long-term obligations that are not classified as debt or specific operational payables. Monitoring this helps identify shifts in long-term financial commitments or deferred obligations.